Seguir
Ross Fulton
Ross Fulton
HiFiBiO Therapeutics
Dirección de correo verificada de hifibio.com
Título
Citado por
Citado por
Año
Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection
RB Fulton, DK Meyerholz, SM Varga
The Journal of Immunology 185 (4), 2382-2392, 2010
2902010
The TCR's sensitivity to self peptide–MHC dictates the ability of naive CD8+ T cells to respond to foreign antigens
RB Fulton, SE Hamilton, Y Xing, JA Best, AW Goldrath, KA Hogquist, ...
Nature immunology 16 (1), 107, 2015
2122015
Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection
KA Weiss, AF Christiaansen, RB Fulton, DK Meyerholz, SM Varga
The Journal of Immunology 187 (6), 3145-3154, 2011
1372011
Effects of aging on the adaptive immune response to respiratory virus infections
RB Fulton, SM Varga
Aging health 5 (6), 775-787, 2009
422009
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity
EM Tam, RB Fulton, JF Sampson, M Muda, A Camblin, J Richards, ...
Science translational medicine 11 (512), eaax0720, 2019
412019
Regulation of cytokine production by virus-specific CD8 T cells in the lungs
RB Fulton, MR Olson, SM Varga
Journal of virology 82 (16), 7799-7811, 2008
412008
Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection
RB Fulton, KA Weiss, LL Pewe, JT Harty, SM Varga
Journal of virology 87 (23), 12694-12700, 2013
392013
T cell epitope specificity and pathogenesis of mouse hepatitis virus-1–induced disease in susceptible and resistant hosts
A Khanolkar, RB Fulton, LL Epping, NL Pham, D Tifrea, SM Varga, ...
The Journal of Immunology 185 (2), 1132-1141, 2010
332010
L]. Kienker,]. R
RJ Fulton, RL McDade, PL Smith
Kettman Jr., Clin. Chem 43, 1749, 1997
18*1997
Synergy between EphA2-ILs-DTXp, a novel EphA2-targeted nanoliposomal taxane, and PD-1 inhibitors in preclinical tumor models
WS Kamoun, AS Dugast, JJ Suchy, S Grabow, RB Fulton, JF Sampson, ...
Molecular Cancer Therapeutics 19 (1), 270-281, 2020
152020
Immune pharmacodynamic responses of the novel cancer immunotherapeutic Imprime PGG in healthy volunteers
N Bose, NR Ottoson, X Qiu, B Harrison, JR Lowe, MT Uhlik, BT Rathmann, ...
The Journal of Immunology 202 (10), 2945-2956, 2019
112019
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...
Journal for immunotherapy of cancer 4, 1-106, 2016
102016
31st annual meeting and associated programs of the society for immunotherapy of cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016
S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ...
Journal for ImmunoTherapy of Cancer 4, 223-242, 2016
92016
Imprime PGG triggers PD-L1 expression on tumor and myeloid cells and prevents tumor establishment in combination with αPD-L1 treatment in vivo
K Fraser, A Chan, R Fulton, S Leonardo, A Jonas, X Qiu, N Ottoson, ...
Cancer Research 76 (14_Supplement), 2335-2335, 2016
92016
CD8+ T cell self-tolerance permits responsiveness but limits tissue damage
EN Truckenbrod, KS Burrack, TP Knutson, H Borges da Silva, KE Block, ...
Elife 10, e65615, 2021
82021
Imprime PGG decreases regulatory T cell suppression and enhances T cell proliferation and differentiation revealing additional mechanisms for its anti-tumor activity
SM Leonardo, K Gorden, R Fulton, L Wurst
Cancer Research 75 (15_Supplement), 5034-5034, 2015
82015
Imprime PGG enhances anti-tumor effects of tumor-targeting, anti-angiogenic, and immune checkpoint inhibitor antibodies
ASH Chan, TO Kangas, X Qiu, MT Uhlik, RB Fulton, NR Ottoson, ...
Frontiers in Oncology 12, 869078, 2022
72022
Abstract B019: Imprime PGG, a soluble β-glucan, binds to and activates dendritic cells resulting in enhanced T cell priming, expansion, and cytokine production
RB Fulton, SM Leonardo, KS Michel, ME Danielson, KB Gorden, JR Graff
Cancer Immunology Research 4 (1_Supplement), B019-B019, 2016
72016
A novel human TNFR2 antibody (MM-401) modulates T cell responses in anti-cancer immunity
JF Sampson, VB Kurella, V Paragas, S Kumar, JE Lulo, JA Qiu, M Razlog, ...
Cancer Res 79 (13 Supplement), 555, 2019
62019
MM-401, a novel anti-TNFR2 antibody that induces T cell co-stimulation, robust anti-tumor activity and immune memory
J Richards, C Wong, A Koshkaryev, R Fulton, A Camblin, J Sampson, ...
Cancer Res 79 (13 Supplement), 4846, 2019
62019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20